Literature DB >> 18269642

Prognostic value of cell adhesion in esophageal adenocarcinomas.

D Falkenback1, M Nilbert, S Oberg, J Johansson.   

Abstract

Increased understanding of the molecular processes associated with the dysplasia-adenocarcinoma sequence linked to Barrett's esophagus may be beneficial for early tumor detection and refined diagnosis as well as for improved prognostication. We applied immunohistochemical staining for the markers Ki-67, p53, beta-catenin and E-cadherin in order to evaluate their prognostic importance in 59 Barrett's esophagus-associated adenocarcinomas. Reduced or absent membranous E-cadherin staining was identified in 75% of the tumors and predicted poor prognosis in manova (hazard ratio [HR] 3.3, P = 0.05). The small subset of tumors with low levels (< 10%) of Ki-67 staining showed a worse prognosis (HR 3.2, P < 0.01), whereas immunostaining for p53 and beta-catenin showed no correlation with prognosis. Deranged cell adhesion has been demonstrated to be an early event in tumor development. The down-regulation of E-cadherin and its prognostic importance indicate that cell adhesion may be a prime area for targeted therapies in esophageal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269642     DOI: 10.1111/j.1442-2050.2007.00749.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  13 in total

Review 1.  Biomarkers of Barrett's esophagus.

Authors:  Yasser Mahrous Fouad; Ibrahim Mostafa; Reem Yehia; Hisham El-Khayat
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

2.  Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells.

Authors:  Matthew D Taylor; Yuan Liu; Alykhan S Nagji; Nicholas Theodosakis; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2010-05       Impact factor: 5.209

Review 3.  Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

Authors:  Chin-Ann J Ong; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 4.  Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.

Authors:  L H McCormick Matthews; F Noble; J Tod; E Jaynes; S Harris; J N Primrose; C Ottensmeier; G J Thomas; T J Underwood
Journal:  Br J Cancer       Date:  2015-06-25       Impact factor: 7.640

Review 5.  Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.

Authors:  Meilan Chen; Jizheng Huang; Zhenli Zhu; Jun Zhang; Ke Li
Journal:  BMC Cancer       Date:  2013-11-11       Impact factor: 4.430

6.  Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.

Authors:  Fiebo J C Ten Kate; Lucia Suzuki; Lambert C J Dorssers; Winand N M Dinjens; David T W Jones; Daan Nieboer; Michael Doukas; J Jan B Van Lanschot; Bas P L Wijnhoven; Leendert H J Looijenga; Katharina Biermann
Journal:  Oncotarget       Date:  2017-10-24

7.  The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging.

Authors:  Matthias C Schauer; Nikolas H Stoecklein; Joerg Theisen; Feride Kröpil; Stephan Baldus; Arnulf Hoelscher; Markus Feith; Edwin Bölke; Christiane Matuschek; Wilfried Budach; Wolfram Trudo Knoefel
Journal:  Eur J Med Res       Date:  2012-05-14       Impact factor: 2.175

8.  GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?

Authors:  Romana Illig; Eckhard Klieser; Tobias Kiesslich; Daniel Neureiter
Journal:  Gastroenterol Res Pract       Date:  2013-03-20       Impact factor: 2.260

9.  High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma.

Authors:  Han-Yu Deng; Zi-Hang Chen; Zhi-Qiang Wang; Yun-Cang Wang; En-Min Li; Li-Yan Xu; Yi-Dan Lin; Long-Qi Chen
Journal:  Oncotarget       Date:  2017-07-21

Review 10.  The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Oliver M Fisher; Sarah J Lord; Dan Falkenback; Nicholas J Clemons; Guy D Eslick; Reginald V Lord
Journal:  Gut       Date:  2016-01-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.